Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity and outcome to neoadjuvant chemotherapy

Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer

(2015) Martin Buess et al.   NEOPLASIA

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis

(2010) Veronique Neumeister et al.   AMERICAN JOURNAL OF PATHOLOGY

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures

(2010) Liheng Zhou et al.   BREAST CANCER RESEARCH AND TREATMENT

Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis

(2010) Paola Marcato et al.   STEM CELLS

Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment

(2009) Erika Resetkova et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

(2009) H Nalwoga et al.   BRITISH JOURNAL OF CANCER

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

(2009) Koji Morimoto et al.   CANCER SCIENCE

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

(2009) E. Charafe-Jauffret et al.   CLINICAL CANCER RESEARCH

Reduction of CD44+/CD24− breast cancer cells by conventional cytotoxic chemotherapy

(2009) Sebastian Aulmann et al.   HUMAN PATHOLOGY

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas

(2008) Eleni Mylona et al.   HUMAN PATHOLOGY

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

(2008) Scott J. Dylla et al.   PLoS One